Bioventus BVS (Settlement) proceeds from the sale of a business
(Settlement) proceeds from the sale of a business at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept bvs:SettlementProceedsFromDivestitureOfBusiness.
The official record: Bioventus’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's (settlement) proceeds from the sale of a business.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's (settlement) proceeds from the sale of a business?
- Bioventus (BVS) reported (settlement) proceeds from the sale of a business of -$171.5K in Q4 2025.
- How has Bioventus's (settlement) proceeds from the sale of a business changed year-over-year?
- Bioventus's (settlement) proceeds from the sale of a business decreased by 102.8% year-over-year, from $6.17M to -$171.5K.
- What is the long-term trend for Bioventus's (settlement) proceeds from the sale of a business?
- Over 2 years (2023 to 2025), Bioventus's (settlement) proceeds from the sale of a business has grown at a -85.9% compound annual growth rate (CAGR), from $34.68M to -$686K.
- What does (settlement) proceeds from the sale of a business mean?
- Represents the cash inflows received from the sale of business units, subsidiaries, or product lines. This metric is used to evaluate the company's capital allocation strategy and the success of its portfolio optimization efforts.